← Leaderboards
Jeffrey C Thompson
University Of Pennsylvania
$982,070
Attributed
$982,070
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $196.4K · FY2018–22$200K$150K$100K$50K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$982,070 · 1
By mechanism
K08$982,070 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Warren S Pear$28,448,095
- Amy Cleveland Durham$1,066,215
- Melpo Christofidou-Solomidou$5,805,617
- Robert H Vonderheide$28,425,019
- David Tuveson$22,023,736
Others in their field
Other Emerging Leaders on “Clinical Predictors”
- Christopher Barnaby Nelson · University Of Melbourne$28,282,846
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
- Julie Stoner · University Of Oklahoma Hlth Sciences Ctr$11,208,548
- Van My Ta Park · University Of Pennsylvania$7,267,985
- Gyungah Jun · University Of Pennsylvania$7,267,985
- Jonathan Flint · University Of California Los Angeles$6,370,758
Research focus
Clinical PredictorsClinical ResearchAdvisory CommitteesCirculating DnaChemotherapyAnti-Pd1 AntibodiesAnti-Pd1 TherapyAntibody TherapyAntineoplastic AgentsCessation Of LifeAnti-Tumor Immune ResponseAwardBaseBioinformaticsBiological MarkersBiopsyCancer CenterCancer EtiologyCancer ImmunobiologyCancer PatientCancer TherapyCareerCd8-Positive T-LymphocytesClinical Trials
Grant awards (5)
A multimodal approach to develop molecular markers to predict response to immune targeted agents in non-small cell lung cancer$196,414
K08 · FY2022 · CA · contact PI
A multimodal approach to develop molecular markers to predict response to immune targeted agents in non-small cell lung cancer$196,414
K08 · FY2021 · CA · contact PI
A multimodal approach to develop molecular markers to predict response to immune targeted agents in non-small cell lung cancer$196,414
K08 · FY2020 · CA · contact PI
A multimodal approach to develop molecular markers to predict response to immune targeted agents in non-small cell lung cancer$196,414
K08 · FY2019 · CA · contact PI
A multimodal approach to develop molecular markers to predict response to immune targeted agents in non-small cell lung cancer$196,414
K08 · FY2018 · CA · contact PI